THE ACCEPTABILITY OF A COMBINED ESTROGEN-PROGESTOGEN CONTRACEPTIVE VAGINAL RING

被引:26
|
作者
WEISBERG, E
FRASER, IS
MISHELL, DR
LACARRA, M
BARDIN, CW
机构
[1] UNIV SYDNEY, SYDNEY CTR REPROD HLTH RES, DEPT OBSTET & GYNAECOL, SYDNEY, NSW 2006, AUSTRALIA
[2] POPULAT COUNCIL, CTR BIOMED RES, NEW YORK, NY 10021 USA
[3] UNIV SO CALIF, SCH MED, DEPT OBSTET & GYNECOL, LOS ANGELES, CA 90033 USA
关键词
CONTRACEPTION; ESTROGEN; PROGESTOGEN VAGINA; RING; ACCEPTABILITY;
D O I
10.1016/0010-7824(94)00005-H
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The acceptability of a vaginal ring releasing ethinyl oestradiol 20 meg per day and norethindrone acetate I mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive method used, contraceptive methods used in the past and their reason for liking or disliking previous contraceptive methods, as well as their reason for stopping the last method. On completion of the study or leaving the study for any reason, each woman was asked to complete an acceptability questionnaire which included her experiences with the ring and the rating of the method. The responses to these two questionnaires form the basis of this report. The overall rating of the ring was similar in both the Sydney and Los Angeles groups. Sixty-nine percent of women rated the method as very good. Seventy-two percent of women in Los Angeles and 62% of women in Sydney liked the ring much more than their most liked previous method. In both groups the method they liked best apart from the ring was the pill (62% in Sydney and 53% in Los Angeles), The major reasons for liking the ring were convenience of use, effectiveness and no requirements for taking medication daily. Most women in both studies would recommend the ring to others (92% in Sydney and 89% in Los Angeles).
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [21] SHORT-TERM CHANGES IN LIPOPROTEINS AND APOPROTEINS DURING CYCLICAL ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY
    FLETCHER, CD
    FARISH, E
    DAGEN, MM
    HART, DM
    MATURITAS, 1991, 14 (01) : 33 - 42
  • [22] Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring
    Nguyen, Brian Trung
    Jensen, Jeffrey T.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (10) : 1423 - 1430
  • [23] Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use
    Merki-Feld, Gabriele S.
    Hund, Martin
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2010, 15 (06) : 413 - 422
  • [24] Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world
    Ridgeway, Kathleen
    Montgomery, Elizabeth T.
    Smith, Kevin
    Torjesen, Kristine
    Straten, Ariane van der
    Achilles, Sharon L.
    Griffin, Jennifer B.
    CONTRACEPTION, 2022, 106 : 16 - 33
  • [25] Pulmonary Embolism With Pulmonary Infarction in a Patient Using the Annovera® Segesterone Acetate and Ethinylestradiol Combined Vaginal Contraceptive Ring
    Mukherjee, Aveek
    Roy, Sasmit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [26] Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol
    Bjarnadóttir, RI
    Tuppurainen, M
    Killick, SR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (03) : 389 - 395
  • [27] An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing®
    Bruni, Vincenzina
    Pontello, Valentina
    Luisi, Stefano
    Petraglia, Felice
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 139 (01): : 65 - 71
  • [28] The contraceptive vaginal ring, NuvaRing®, a decade after its introduction
    Roumen, Frans J. M. E.
    Mishell, Daniel R., Jr.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2012, 17 (06) : 415 - 427
  • [29] Aortic thrombus with contraceptive vaginal ring use
    Smith, Katharyn L.
    Bolton, Kimberly J.
    Weger, Natalie S.
    Hobbs, Ryan A.
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2023, 53 (02) : 87 - 90
  • [30] Contraceptive vaginal ring reduces lamotrigine levels
    King, Alexa
    Bachman, Elizabeth
    Macken, Micheal P.
    Lee, Jungwha
    Gerard, Elizabeth E.
    EPILEPSY & BEHAVIOR, 2020, 111